I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 2.8 USD 14.29%
Market Cap: 226.5m USD

Wall Street
Price Targets

IMAB Price Targets Summary
I-Mab

Wall Street analysts forecast IMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMAB is 5.51 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.04 USD
44% Upside
Average
Price Target
5.51 USD
97% Upside
Highest
Price Target
7.35 USD
163% Upside
I-Mab Competitors:
Price Targets
ONCO
Oncopeptides AB
282% Upside
300009
Anhui Anke Biotechnology Group Co Ltd
21% Upside
6855
Ascentage Pharma Group International
7% Downside
XGN
Exagen Inc
10% Upside
CSL
CSL Ltd
32% Upside
VITR
Vitrolife AB
50% Upside

Revenue
Forecast

Revenue Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMAB's stock price target?
Price Target
5.51 USD

According to Wall Street analysts, the average 1-year price target for IMAB is 5.51 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Back to Top